» Articles » PMID: 31384939

British Kindred with Dominant FMF Associated with High Incidence of AA Amyloidosis Caused by Novel MEFV Variant, and a Review of the Literature

Overview
Specialty Rheumatology
Date 2019 Aug 7
PMID 31384939
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Hereditary systemic autoinflammatory diseases are rare genetic disorders, which if untreated, can be complicated by AA amyloidosis leading to renal failure and premature death. Our objective was to find a genetic cause in a British family with a dominantly inherited autoinflammatory disease complicated by AA amyloidosis.

Methods: The index patient and his sister underwent comprehensive clinical and laboratory assessment including the next-generation sequencing panel targeting autoinflammatory genes. Subsequently, other relatives underwent clinical evaluation and genetic testing. Screening of the SAA1 gene was performed in all symptomatic cases.

Results: The index case and his sister presented with proteinuria due to AA amyloidosis. They have been suffering from episodes of fever accompanied by severe abdominal and chest pain, arthritis and erythema since childhood. Their father died aged 52 years from complications following a cadaveric renal transplantation. The post-mortem examination demonstrated AA amyloidosis. The index case's grandmother, two paternal cousins and two of their children described similar symptoms. All symptomatic individuals had excellent responses to colchicine. Next-generation sequencing analysis identified a single MEFV p.P373L variant in the index case, his sister and subsequently, in symptomatic family members. Sequencing of the SAA1 gene revealed all cases were heterozygous for the SAA1.1 allele.

Conclusion: Typically FMF is an autosomal recessive disorder; nonetheless rare cases of dominantly inherited disease have previously been described. Here we report a novel MEFV variant p.P373L, causing dominant FMF complicated by AA amyloidosis in four generations of a British family.

Citing Articles

The journey of MEFV heterozygous children: with or without colchicine.

Cakan M, Alkaya A, Koru L, Oksel B, Akgun O, Tunce E Eur J Pediatr. 2024; 184(1):40.

PMID: 39581919 DOI: 10.1007/s00431-024-05887-8.


A narrative review on the role of cytokines in the pathogenesis and treatment of familial Mediterranean fever: an emphasis on pediatric cases.

Chaaban A, Yassine H, Hammoud R, Kanaan R, Karam L, Ibrahim J Front Pediatr. 2024; 12:1421353.

PMID: 39132307 PMC: 11310175. DOI: 10.3389/fped.2024.1421353.


Updates on the role of epigenetics in familial mediterranean fever (FMF).

Chaaban A, Salman Z, Karam L, Kobeissy P, Ibrahim J Orphanet J Rare Dis. 2024; 19(1):90.

PMID: 38409042 PMC: 10898143. DOI: 10.1186/s13023-024-03098-w.


The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.

La Bella S, Di Ludovico A, Di Donato G, Basaran O, Ozen S, Gattorno M Front Immunol. 2024; 14:1341680.

PMID: 38250061 PMC: 10796709. DOI: 10.3389/fimmu.2023.1341680.


Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.

Chirita D, Bronnec P, Magnotti F, Dalmon S, Martin A, Popoff M Cell Death Dis. 2023; 14(3):213.

PMID: 36966139 PMC: 10039897. DOI: 10.1038/s41419-023-05745-9.